MedPath

ID-1201

Generic Name
ID-1201

Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease

Phase 2
Completed
Conditions
Alzheimer Disease
Interventions
First Posted Date
2017-12-06
Last Posted Date
2019-06-04
Lead Sponsor
IlDong Pharmaceutical Co Ltd
Target Recruit Count
116
Registration Number
NCT03363269
Locations
🇰🇷

Dong-A University Hospital, Busan, Korea, Republic of

🇰🇷

Myongji Hospital, Goyang, Korea, Republic of

🇰🇷

Daejeon Eulji Medical Center, Eulji University, Daejeon, Korea, Republic of

and more 17 locations
© Copyright 2025. All Rights Reserved by MedPath